Apotheken | Arzt | Interaktionen | Medikamente | MiGeL | Services | Spital | Zulassungsi.
Fachinformation zu Qutenza® kutanes Pflaster:Grünenthal Pharma AG
Vollst. FachinformationDDDÄnderungen anzeigenDrucken 
Fahrtücht.Unerw.WirkungenÜberdos.Eigensch.Pharm.kinetikPräklin.Sonstige H.Swissmedic-Nr.
PackungenReg.InhaberStand d. Info. 
N01BX04 - CapsaicinATC-DDD Version 2016. Source: WHO
N - Nervous System
N01 - Anesthetics

No DDDs have been established in this group because the doses used vary substantially.

N01B - Anesthetics, Local

Local anesthetics in this context mean anesthetics which only affect a local area as opposed to general anesthetics affecting the entire body.
Creams, plasters and sprays containing e.g. lidocaine or prilocaine used as anesthetics/analgesics or in premature ejaculation are classified in N01BB.
Local anesthetics for dermatological use such as treatment of pruritus, minor burns and insect stings are classified in D04AB - Anesthetics for topical use.
Antihemorrhoidals containing anesthetics, see C05AD - Local anesthetics.
Stomatologicals with anesthetics, see A01AD.
Combinations of corticosteroids and anesthetics for oral local treatment, see A01AC.
Throat preparations with anesthetics, see R02AD - Anesthetics, local.
Ophthalmological anesthetics, see S01HA.
Combinations with e.g. epinephrine are classified at separate 5th levels by using the 50-series.

N01BX - Other Local Anesthetics

Capsaicin products indicated for the symptomatic treatment of peripheral neuropathic pain (incl. postherpetic neuralgia) are classified in N01BX. See also M02AB.

N01BX04 - Capsaicin
2022 ©ywesee GmbH
Einstellungen | Hilfe | FAQ | Anmeldung | Kontakt | Home